Loading candles…
Amanta Healthcare Limited, incorporated in December 1994, operates in the pharmaceutical industry specializing in the development, manufacture, and marketing of sterile liquid pharmaceutical products. The company's product portfolio includes intravenous (IV) solutions and respiratory care products. It functions through two main business segments: Large Volume Parenterals (LVP) and Small Volume Parenterals (SVP). Amanta Healthcare Limited serves both domestic and international markets, offering its products through proprietary branded generics and institutional sales. The company does not have listed subsidiaries or notable projects detailed in the available information, nor are there disclosures about its key management or founders.
This page is a live market overview for AMANTA HEALTHCARE LIMITED (AMANTA) on the NSE. As a listed security, AMANTA HEALTHCARE LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for AMANTA before placing trades on tick2trade.
As of the latest feed, AMANTA last traded at ₹189.21 on NSE, up ₹3.71 (2.00%) from the previous close of ₹185.5. Today's session range is ₹182 – ₹189.21, against a 52-week band of ₹92 – ₹209.95. Traded volume today stands at 39.04K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for AMANTA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether AMANTA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for AMANTA HEALTHCARE LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in AMANTA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated AMANTA option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 5 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 19 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 10 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 11 Nov 2025 |
| Results - Q1-FY25 | To consider Financial Results for Quarter June 2025 | 26 Sep 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.